Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2013-07-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2013.06.032PMID 23792097
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HDAC6 and Ovarian Cancer

  2013cited by this paper
• Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells

  2013cited by this paper
• Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

  2012cited by this paper
• Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives.

  2012cited by this paper
• Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress

  2011cited by this paper
• HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.

  2011cited by this paper
• Autophagy as a target for anticancer therapy

  2011cited by this paper
• Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells

  2011cited by this paper
• Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection.

  2011cited by this paper
• Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress.

  2011cited by this paper
• Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells

  2011cited by this paper
• Clarithromycin attenuates autophagy in myeloma cells.

  2010cited by this paper
• Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents

  2010cited by this paper
• Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy

  2010cited by this paper
• Mechanisms of cross‐talk between the ubiquitin‐proteasome and autophagy‐lysosome systems

  2010cited by this paper
• Autophagy in mammalian development and differentiation

  2010cited by this paper
• A role for ubiquitin in selective autophagy.

  2009cited by this paper
• Effect of autophagy on multiple myeloma cell viability

  2009cited by this paper
• Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation.

  2008cited by this paper
• The aggresome pathway as a target for therapy in hematologic malignancies.

  2008cited by this paper
• Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA.

  2008cited by this paper
• Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.

  2007cited by this paper
• Signal integration in the endoplasmic reticulum unfolded protein response

  2007cited by this paper
• CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism

  2005cited by this paper
• Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation

  2003cited by this paper
• The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.

  2003cited by this paper
• Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes.

  2002cited by this paper
• CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum.

  1998cited by this paper
• CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription.

  1992cited by this paper

• Erastin plus Tubacin Treatment Promotes Breast Cancer Cell Death of HCC38

  2023cites this paper
• MHY446 induces apoptosis via reactive oxygen species-mediated endoplasmic reticulum stress in HCT116 human colorectal cancer cells

  2023cites this paper
• Study on the Role and Mechanism of HDAC6 in Cd-Induced Inflammation and Fibrosis in Mice Liver

  2023cites this paper
• The Advances in Epigenetics for Cancer Radiotherapy

  2022cites this paper
• Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing

  2022cites this paper
• Induction of synergistic non-apoptotic cell death by simultaneously targeting proteasomes with bortezomib and histone deacetylase 6 with ricolinostat in head and neck tumor cells

  2021cites this paper
• Vorinostat (SAHA) and Breast Cancer: An Overview

  2021cites this paper
• Pathophysiology of Obesity and Cancer: Drugs and Signaling Targets

  2021cites this paper
• Histone deacetylase inhibitor Vorinostat (SAHA) suppresses micropthalmia transcription factor expression and induces cell death in nevocytes from large/giant congenital melanocytic nevi

  2021cites this paper
• Re-sensitizing tumor cells to cancer drugs with epigenetic regulators.

  2021cites this paper
• Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?

  2021cites this paper
• Drug repositioning for the treatment of hematologic disease: limits, challenges and future perspectives.

  2020cites this paper
• Vimentin's side gig: Regulating cellular proteostasis in mammalian systems

  2020cites this paper
• Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K

  2020cites this paper
• Understanding Breast cancer: from conventional therapies to repurposed drugs.

  2020cites this paper
• Mechanistic studies of a novel inhibitor of the ubiquitin-proteasome system

  2019cites this paper
• Suberoylanilide Hydroxamic Acid Can Re-sensitize a Cisplatin-Resistant Human Bladder Cancer.

  2019cites this paper
• Autophagy induced by SAHA affects mutant P53 degradation and cancer cell survival

  2019cites this paper
• Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation.

  2019cites this paper
• Selective Histone Deacetylase 6 Inhibitor 23BB Alleviated Rhabdomyolysis-Induced Acute Kidney Injury by Regulating Endoplasmic Reticulum Stress and Apoptosis

  2018cites this paper
• Designing an effective drug combination for ER stress loading in cancer therapy using a real-time monitoring system.

  2018cites this paper
• NF-κB pathway link with ER stress-induced autophagy and apoptosis in cervical tumor cells

  2017cites this paper
• Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathways.

  2017cites this paper
• Combination therapy in combating cancer

  2017cites this paper
• Epigenetic Mechanism in Breast Cancer

  2016cites this paper
• Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines

  2016cites this paper
• Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines

  2016cites this paper
• Pro-oxidative Phytoagents Induce Autophagy in Tumors

  2016cites this paper
• HDAC6 as a Therapeutic Candidate in the Treatment of Inflammatory Breast Cancers

  2015cites this paper
• Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent

  2015cites this paper
• Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast Cancer

  2015cites this paper
• Therapeutic targeting of autophagy in cancer. Part II: pharmacological modulation of treatment-induced autophagy.

  2015cites this paper
• MDM2 Inhibitor, Nutlin 3a, Induces p53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation

  2015cites this paper
• Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits

  2015cites this paper
• An inhibitor of ubiquitin conjugation and aggresome formation† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc01351h Click here for additional data file.

  2015cites this paper
• Therapeutic targeting of autophagy in cancer. Part I: molecular pathways controlling autophagy.

  2015cites this paper
• EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells.

  2015cites this paper
• Targeting Selective Autophagy of Insoluble Protein Aggregates: The Sniper’s Philosophy

  2015cites this paper
• Limited efficacy of specific HDAC6 inhibition in urothelial cancer cells

  2014cites this paper
• Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress-mediated cell death in multiple myeloma cells

  2014cites this paper
• Suberoyl bis-hydroxamic acid enhances cytotoxicity induced by proteasome inhibitors in breast cancer cells

  2014cites this paper